Experienced in generating patented IP.
As part of our CDMO service, our proven experience in generating patentable intellectual property can accelerate your program’s patent protection goals.
The Australia Federal Government announced in the May 2021 Federal Government Budget a patent box program, designed to encourage innovation and investment in the Australia’s biotech and medical industries.
Working with Mayne Contract Services in Australia may provide your program access to the benefits of the patent box, which is planned to take effect from 1 July 2022.
Mayne Pharma has an impressive record of pharmaceutical innovation, creating patentable pharmaceutical IP globally. Since 1929, Mayne Pharma has achieved:
- 60+ patent applications with more than 25 granted in Australia
- 340+ patent applications in other countries around the world.